antifungal resistance

Cwh8 moonlights as a farnesyl pyrophosphate phosphatase and is essential for farnesol biosynthesis in Candida albicans

mycolabadmin

Candida albicans is a common fungus that causes serious infections in people with weakened immune systems. The fungus produces a molecule called farnesol that prevents it from growing in long filaments, which are associated with virulence. Researchers discovered that an enzyme called Cwh8 is absolutely essential for making farnesol, and when this enzyme is missing, the fungus becomes highly sensitive to the antifungal drug fluconazole, suggesting a potential strategy to overcome drug resistance.

High‐Throughput Culture and DNA Isolation Methods for Aspergillus fumigatus

mycolabadmin

Scientists have developed a faster, cheaper way to grow and extract DNA from Aspergillus fumigatus, a fungus that causes serious infections in sick people. Using 96-well plates (the same format used in many laboratories), researchers can now process many samples at once instead of handling them one by one. The method works well for identifying drug-resistant fungal strains and preparing DNA for genetic analysis.

Fungal Metabolomics: A Comprehensive Approach to Understanding Pathogenesis in Humans and Identifying Potential Therapeutics

mycolabadmin

This review explains how scientists use metabolomics—a technique that identifies all chemical compounds in organisms—to understand how fungi cause disease and resist medicines. Fungi produce many different chemicals that help them attack our bodies and survive treatments, but these same chemicals could also be used to create new medicines. By studying these fungal chemicals, researchers can develop better antifungal drugs and understand how fungi manage to evade our immune system.

Clinical Isolate of Candida tropicalis from a Patient in North Carolina: Identification, Whole-Genome Sequence Analysis, and Anticandidal Activity of Ganoderma lucidum

mycolabadmin

Researchers in North Carolina identified a drug-resistant yeast infection (Candida tropicalis) from a hospital patient and tested whether extracts from reishi mushrooms (Ganoderma lucidum) could kill it. Using genetic analysis, they found mutations in the yeast that help it resist antifungal drugs. All three types of mushroom extracts tested successfully stopped the yeast’s growth and damaged its cells, suggesting that reishi mushrooms could be a promising natural treatment option for hard-to-treat candida infections.

Challenges in Identifying Uncommon Clinical Isolates of Candida Species Using Conventional Phenotypic Methods: A Clinical Concern

mycolabadmin

This study examined different methods for identifying Candida fungi in patient samples from a hospital in rural India. Researchers found that a dangerous fungus called Candida auris was being misidentified by traditional laboratory methods, while a newer automated system identified it correctly. The study also showed that many Candida infections are becoming resistant to common antifungal drugs, highlighting the need for better identification methods and careful drug selection.

The emerging fungal pathogen Cryptococcus gattii: Epidemiology, pathogenesis, immunomodulatory attributes, and drug susceptibility

mycolabadmin

Cryptococcus gattii is a dangerous fungal infection that can affect even healthy people, unlike most fungal infections that target those with weak immune systems. The fungus uses clever tricks to hide from the immune system, including creating protective capsules and producing melanin. Current antifungal drugs like fluconazole are becoming less effective as the fungus develops resistance, making this an urgent public health concern that requires better treatments and early detection.

Emergence of Rhodotorula mucilaginosa among pet animals: a possible public health risk on the move

mycolabadmin

Researchers discovered that a fungus called Rhodotorula mucilaginosa is increasingly infecting pet dogs and cats, particularly in their ears and nasal passages. This yeast was previously thought to be harmless but is now recognized as a disease-causing pathogen that shows resistance to many common antifungal medications. The study raises important concerns about the potential transmission of this infection from pets to their human caregivers, suggesting pet owners should be aware of this emerging health risk.

What Do We Know About Cryptococcus spp. in Portugal? One Health Systematic Review in a Comprehensive 13-Year Retrospective Study (2013–2025)

mycolabadmin

This study examines cryptococcosis, a fungal infection that affects both animals and humans, across Portugal from 2013-2025. Researchers found that about 4.5% of animal samples tested positive for Cryptococcus species, with infections most common in dogs and cats. The infections peaked during summer months and were most prevalent in central Portugal, with different fungal species affecting different animal types. The research emphasizes the importance of coordinated monitoring across animals, humans, and the environment to better understand and control this disease.

Addressing Critical Fungal Pathogens Under a One Health Perspective: Key Insights from the Portuguese Association of Medical Mycology

mycolabadmin

Four dangerous fungal species pose growing threats to human health worldwide, especially for people with weakened immune systems. Portugal’s medical experts have reviewed the current situation, finding these fungi increasingly resistant to treatment, present in hospitals and the environment, and occasionally spreading from animals to people. The review emphasizes the need for better testing, coordinated tracking systems, and approaches that consider human, animal, and environmental health together to combat this emerging crisis.

Ploidy plasticity drives fungal resistance to azoles used in agriculture and clinics

mycolabadmin

Agricultural fungicides called azoles can cause fungi to change their genetic makeup in ways that make them resistant to medical antifungal drugs. Researchers found that when Candida tropicalis (a fungal pathogen) is exposed to tebuconazole, an agricultural fungicide, it can transform into a haploid form (with half the normal chromosomes) that is resistant to both agricultural and clinical azoles. This discovery helps explain why fungal infections are becoming harder to treat in hospitals.

Research Topic: antifungal resistance